Inverness Medical CE marks rapid HIV test
This article was originally published in Clinica
Inverness Medical has CE marked a rapid HIV diagnostic, Determine HIV 1/2 Ag/Ab Combo, for sale in Europe. The test can detect HIV infection an average of five days earlier than antibody-only tests, the Waltham, Massachusetts firm claims. This is because it can identify the HIV p24 antigen as well as HIV antibodies – p24 is present during the first few weeks of HIV infection, before antibodies are produced. The point-of-care diagnostic provides results in 20 minutes, has a sensitivity of 100% for patients at a chronic stage of infection, and a specificity of 99.23% for HIV antibodies and 99.66% for the HIV-1 p24 antigen.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.